Key result
The pharmacist-led New Medicine Service significantly improved patient satisfaction with medication information (median SIMS score 13 vs 10, p<0.001) and self-efficacy compared to usual care.
Why the study?
Patients starting long-term cardiovascular medicines during the transition from hospital to home are prone to drug-related problems, and real-world evaluation of the New Medicine Service was needed.
Does a pharmacist-led New Medicine Service improve patient satisfaction, self-efficacy, and identify drug-related problems in cardiovascular patients transitioning to primary care?
Cohort (n=839)
Yes
Does a pharmacist-led New Medicine Service improve patient satisfaction, self-efficacy, and identify drug-related problems in cardiovascular patients transitioning to primary care?
Implementing a pharmacist-led New Medicine Service in transitional care improves patient satisfaction and self-efficacy while identifying a high rate of drug-related problems in patients starting new cardiovascular medications.
Answers are grounded in this paper and cite their sources.
May support DRP identification in care transitions; hypothesis-generating for NMS in cardiovascular patients.
BACKGROUND: Patients transitioning from hospital to home while starting long-term cardiovascular medicines are likely to experience drug-related problems (DRPs). The New Medicine Service (NMS) may support readmission to primary care. AIM: To evaluate NMS in a real world setting, for patients transitioning from hospital to primary care with newly prescribed cardiovascular medicines on identifying DRPs, patient satisfaction with medication information and patient self-efficacy. Secondary objectives were identifying risk factors for DRPs and assessing first-fill discontinuation. METHOD: A cohort study in an outpatient pharmacy and 14 community pharmacies in Almere, the Netherlands, involved patients ≥ 18 years receiving new cardiovascular prescriptions. Usual pharmacy care was complemented with a telephone counselling two weeks post-dispensing to identify and address DRPs. Patient satisfaction and self-efficacy were assessed during a follow-up call. First-fill discontinuation was measured using dispensing data, and logistic regression identified risk factors for DRPs. RESULTS: Of 1647 eligible patients, 743 received NMS; 72.5% experienced ≥ 1 DRP. NMS improved patients' satisfaction with information and self-efficacy (p < 0.001). Outpatient visits (adj. OR 0.64), cardiovascular medicine use (adj. OR 0.65), and use of chronic medicines (adj. OR 1.71) influenced DRPs. First-fill discontinuation remained unchanged post-NMS, but patients with DRPs discontinued more often (14.8% vs. 8.6%, p = 0.030). CONCLUSION: Implementing the NMS in a real-world transitional care setting allowed pharmacists to identify DRPs and provide counselling tailored to patient needs. Patients reported higher satisfaction with information and increased self-efficacy. Priority should be given to at-risk patients for DRPs, and deploy other pharmacy staff to perform the NMS.
No takes yet. Share an insight, caveat, or question.
Ensing et al. (2024) conducted a cohort in Cardiovascular disease requiring new medication (n=839). Pharmacist-led New Medicine Service (NMS) vs. Usual pharmacy care was evaluated on Satisfaction with Information about Medicines Scale (SIMS) score (p=<0.001). The pharmacist-led New Medicine Service significantly improved patient satisfaction with medication information (median SIMS score 13 vs 10, p<0.001) and self-efficacy compared to usual care.
Synapse has enriched 10 related papers. Consider them for comparative context: